Thor Medical Stock Börse Stuttgart
Stocks
8NN
NO0010597883
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Tradegate
01:39:19 01/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.5370 EUR | -1.47% |
|
-11.09% | +28.54% |
| 28/08 | Thor Medical ASA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 28/08 | Thor Medical ASA, H1 2026 Earnings Call, Aug 28, 2026 |
| Market Cap | 2.16B 231M 199M 186M 170M 321M 22.06B 322M 2.21B 863M 11.14B 867M 848M 36.92B | P/E 2026 * |
-42.9x | P/E 2027 * | -54.6x |
|---|---|---|---|---|---|
| Enterprise Value | 2.35B 250M 216M 202M 185M 348M 23.92B 349M 2.4B 936M 12.08B 940M 919M 40.05B | EV / Sales 2026 * |
47.9x | EV / Sales 2027 * | 13.9x |
| Free-Float |
59.77% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Thor Medical
| 1 week | -11.09% | ||
| Current month | +3.02% | ||
| 1 month | +35.57% | ||
| 3 months | +29.30% | ||
| 6 months | +46.90% | ||
| Current year | +28.54% |
| 1 week | 0.53 |  | 0.66 |
| 1 month | 0.4 | | 0.66 |
| 3 years | 0.05 | | 0.66 |
| 5 years | 0.04 | | 3.03 |
| 10 years | 0.04 | | 13.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jasper Kurth
CEO | Chief Executive Officer | 41 | 01/08/2024 |
| Director of Finance/CFO | 37 | 01/07/2023 | |
Sindre Hassfjell
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 28/06/2023 | |
John Andersen
CHM | Chairman | 59 | - |
| Director/Board Member | - | 24/04/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.47% | -11.09% | +132.41% | +417.08% | 231M | |
| -1.66% | -4.96% | +49.84% | +88.43% | 69.54B | |
| -2.19% | +1.32% | +44.54% | +88.38% | 64.97B | |
| -3.57% | -4.24% | +47.11% | +5.60% | 26.51B | |
| +1.14% | -3.21% | -17.41% | +448.20% | 25.89B | |
| -0.48% | -9.92% | +1.00% | -15.96% | 25.64B | |
| -9.71% | -0.36% | +245.87% | +377.68% | 20.22B | |
| -1.58% | +0.47% | +29.35% | -19.62% | 19.98B | |
| -3.36% | -7.58% | +9.47% | +535.81% | 15.69B | |
| -0.21% | -0.46% | +46.05% | +142.52% | 13.49B | |
| Average | -2.40% | -3.70% | +58.82% | +206.81% | 31.33B | |
| Weighted average by Cap. | -2.19% | -3.50% | +47.99% | +144.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 49M 5.23M 4.5M 4.22M 3.86M 7.26M 500M 7.29M 50.1M 19.55M 252M 19.63M 19.2M 836M | 168M 17.92M 15.44M 14.48M 13.22M 24.9M 1.71B 24.98M 172M 67.02M 865M 67.29M 65.82M 2.87B |
| Net income | -49M -5.23M -4.5M -4.22M -3.86M -7.26M -500M -7.29M -50.1M -19.55M -252M -19.63M -19.2M -836M | -40M -4.27M -3.68M -3.45M -3.15M -5.93M -408M -5.95M -40.9M -15.96M -206M -16.02M -15.67M -683M |
| Net Debt | 183M 19.52M 16.82M 15.77M 14.4M 27.12M 1.87B 27.21M 187M 73.01M 942M 73.29M 71.7M 3.12B | 177M 18.88M 16.27M 15.25M 13.93M 26.23M 1.8B 26.32M 181M 70.61M 911M 70.89M 69.35M 3.02B |
Employees
-
| Date | Price | Change |
|---|---|---|
| 01/09/26 | EUR 0.5340 | -2.02% |
| 28/08/26 | EUR 0.5450 | -11.81% |
| 27/08/26 | EUR 0.6180 | -2.52% |
| 26/08/26 | EUR 0.6340 | +2.92% |
| 25/08/26 | EUR 0.6160 | -5.52% |
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
6.010NOK
Average target price
3.500NOK
Spread / Average Target
-41.76%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NANOV Stock
- 8NN Stock
Select your edition
All financial news and data tailored to specific country editions
